Jemal Abdela
A5049872980- Pharmaceutical Practices and Patient Outcomes
- Global Health Care Issues
- Global Maternal and Child Health
- Health disparities and outcomes
- Global Public Health Policies and Epidemiology
- Healthcare Systems and Reforms
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Climate Change and Health Impacts
- Pharmaceutical studies and practices
- Natural Antidiabetic Agents Studies
- Respiratory viral infections research
- Antibiotic Use and Resistance
- Child Nutrition and Water Access
- Global Health and Epidemiology
- Pneumonia and Respiratory Infections
- Pharmacological Effects and Toxicity Studies
- Air Quality and Health Impacts
- Quinazolinone synthesis and applications
- Blood properties and coagulation
- Synthesis and bioactivity of alkaloids
- Agricultural Practices and Plant Genetics
- Pharmacovigilance and Adverse Drug Reactions
- Brain Metastases and Treatment
- Glioma Diagnosis and Treatment
Haramaya University
2016-2024
Institute for Health Metrics and Evaluation
2018
University of Washington
2018
BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) includes a comprehensive assessment incidence, prevalence, years lived with disability (YLDs) for 354 causes in 195 countries territories from 1990 to 2017. Previous GBD studies have shown how the decline mortality rates 2016 has led an increase life expectancy, ageing global population, expansion non-fatal burden disease injury. These also substantial portion world's population experiences health loss...
BackgroundGlobal development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, selected locations, subnational cause-specific mortality beginning in year 1980. Here we report an update to that study, making use newly available data improved methods. GBD 2017 provides comprehensive assessment 282 causes 195 countries...
BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to factor quantification that offers useful tool for synthesising evidence on risks risk–outcome associations. With each annual GBD study, we update the CRA incorporate improved methods, new pairs, data exposure levels associations.MethodsWe used framework developed previous iterations estimate trends in exposure, attributable deaths,...
BackgroundHow long one lives, how many years of life are spent in good and poor health, the population's state health leading causes disability change over time all have implications for policy, planning, provision services. We comparatively assessed patterns trends healthy expectancy (HALE), which quantifies number expected to be lived complementary measure disability-adjusted life-years (DALYs), a composite disease burden capturing both premature mortality prevalence severity ill 359...
BackgroundThe number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding disease burden. We aimed present first detailed analysis global prevalence, mortality, overall burden as captured by Global Burden Diseases, Injuries, Risk Factors (GBD) Study 2016, highlight most important messages for clinicians neurologists.MethodsGBD 2016...
Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department Economics Social Affairs (UNPOP), United States Census Bureau, WHO, as part previous iterations Global Burden Diseases, Injuries, Risk Factors Study (GBD). Previous GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent with numbers deaths GBD. The present iteration GBD, 2017, improves on assessments provides timely experience...
A key component of achieving universal health coverage is ensuring that all populations have access to quality care. Examining where gains occurred or progress has faltered across and within countries crucial guiding decisions strategies for future improvement. We used the Global Burden Diseases, Injuries, Risk Factors Study 2016 (GBD 2016) assess personal health-care with Healthcare Access Quality (HAQ) Index 195 territories, as well subnational locations in seven countries, from 1990 2016.
Seizures and their consequences contribute to the burden of epilepsy because they can cause health loss (premature mortality residual disability). Data on are needed for health-care planning resource allocation. The aim this study was quantify due by age, sex, year, location using data from Global Burden Diseases, Injuries, Risk Factors Study.We assessed in 195 countries territories 1990 2016. measured as deaths, prevalence, disability-adjusted life-years (DALYs; a summary measure defined...
Brain and CNS cancers (collectively referred to as cancers) are a source of mortality morbidity for which diagnosis treatment require extensive resource allocation sophisticated diagnostic therapeutic technology. Previous epidemiological studies limited specific geographical regions or time periods, making them difficult compare on global scale. In this analysis, we aimed provide comparable comprehensive estimation the burden brain cancer between 1990 2016.We report means 95% uncertainty...
BackgroundAlthough the burden of influenza is often discussed in context historical pandemics and threat future pandemics, every year a substantial lower respiratory tract infections (LRTIs) other conditions (like chronic obstructive pulmonary disease) are attributable to seasonal influenza. The Global Burden Disease Study (GBD) 2017 systematic scientific effort quantify health loss associated with comprehensive set diseases disabilities. In this Article, we focus on LRTIs that can be...
BackgroundEfforts to establish the 2015 baseline and monitor early implementation of UN Sustainable Development Goals (SDGs) highlight both great potential for threats improving health by 2030. To fully deliver on SDG aim “leaving no one behind”, it is increasingly important examine health-related SDGs beyond national-level estimates. As part Global Burden Diseases, Injuries, Risk Factors Study 2017 (GBD 2017), we measured progress 41 52 indicators estimated index 195 countries territories...
BackgroundPopulation estimates underpin demographic and epidemiological research are used to track progress on numerous international indicators of health development. To date, internationally available population fertility, although useful, have not been produced with transparent replicable methods do use standardised mortality. We present single-calendar year single-year age fertility by sex methods.MethodsWe estimated in 195 locations single calendar from 1950 2017 methods. based the...
Acute meningitis has a high case-fatality rate and survivors can have severe lifelong disability. We aimed to provide comprehensive assessment of the levels trends global burden that could help guide introduction, continuation, ongoing development vaccines treatment programmes.
Background Patients who suffer from surgical site infections (SSIs) bear a heavy clinical burden. Longer hospital stays are more likely for patients with SSIs because they to require treatment in an intensive care unit or be readmitted the hospital. Drug-resistant bacterial becoming common, which is one of main challenges effectively treating hospitals. Objective The study aimed determine incidence, isolates, and susceptibility patterns among had undergone major procedures eastern Ethiopia....
Aims: This study was designed to assess knowledge, attitude and practices of adverse drug reaction reporting among healthcare professionals in Hiwot Fana Specialized University Hospital (HFSUH). Method: based descriptive cross sectional conducted on HFSUH. Based purposive sampling technique, all eligible (nurses, physicians pharmacists) were involved the study. A pretested self-administered questionnaire used collect data. Data coded, entered analyzed using SPSS version 16. The test...
Pharmacotherapy is important in reducing morbidity and mortality related to cardiovascular diseases. However, these advantages are limited by drug therapy problems that can impact on a patient's quality of life, prolong hospital stays, increase the overall burden healthcare expenditures. Therefore, this study was aimed assess among patients with diseases who were hospitalized received follow-up at ambulatory clinic Hiwot Fana Specialized University Hospital.An institution-based...
Background: Rational prescribing, dispensing and patient use are the major components of rational drug use; however, actual pattern is not in line with World Health Organization (WHO) guidelines often irrational many healthcare settings, particularly developing countries.Therefore, this study aimed to highlight general prescribing practices at Hiwot Fana Specialized University Hospital (HFSUH) outpatient settings.Method: Across-sectional design was employed determine medication HFSUH.As per...
Background: Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the characteristic hyperglycemia.It is associated with abnormalities in carbohydrate, fat, and protein metabolism results chronic complications including microvascular, macrovascular, neuropathic disorders.Evidence indicates it level blood glucose, which patients can achieve during their treatment, influences diabetic on long run.Achievement optimal sugar generally based appropriate utilization...
Traditionally people used Dodonaea viscosa for the treatment of various ailments, including diarrhea. Therefore, this study was aimed to evaluate antidiarrheal activity 80% methanolic leaf extract D against castor oil-induced diarrhea in mice models. Different doses (100, 200, and 400 mg/kg) were evaluated their activities using oil–induced diarrhea, gastrointestinal transit, enteropooling models Swiss albino mice. At all test doses, plant showed significant ( P < .05) inhibition...